Starpharma Holdings (SPL) is a biotechnology company that engages in the development of dendrimer products for pharmaceutical, life science and other applications.
Its underlying technology is built around dendrimers, a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical uses.
SPL has two core development programs: VivaGel portfolio and DEP drug delivery.